Processa Pharmaceuticals Competitors and Similar CompaniesClear all
Processa Pharmaceuticals's competitors and similar companies include Takeda and Prolong Pharmaceuticals.
 Processa Pharmaceuticals Processa Pharmaceuticals (formerly Heatwurx) is a company focused on developing treatments for patients with an unmet medical need. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Prolong Pharmaceuticals Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia. | |
Founding Date | Founding Date 2017 | Founding Date 1781 | Founding Date 2005 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Hanover, US HQ | Locations South Plainfield, US HQ | |
Employees | Employees 1033% decrease | Employees 47,4554% decrease | Employees 225% increase |
Valuation ($) | Valuation ($) 4.4 m | Valuation ($) 43.7 b | Valuation ($) N/A |
Financial | |||
Net income | Net income ($13.6m) (FY, 2025) | Net income ¥108.1b (FY, 2025) | Net income N/A |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products 1 (Oct, 2020) | Phase I Trials Products 2 (May, 2025) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 2 (Oct, 2020) | Phase II Trials Products 10 (May, 2025) | Phase II Trials Products N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyProlong Pharmaceuticals
HQ
South Plainfield, US
Employees
22↑ 5% increase
Prolong Pharmaceuticals is a company providing SANGUINATE, a medication focusing on treating sickle cell disease and other disorders caused by anemia, hypoxia, or ischemia.
View company